Diligence memo · auto-generated · as of July 2, 2026
Hypertension Diagnostics Inc /Mn
Hypertension Diagnostics Inc /Mn looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Hypertension Diagnostics Inc /Mn operates in Biotechnology, based in MINNETONKA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Hypertension Diagnostics Inc /Mn has raised $834K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $834K on 2012-03-01.
Most recent recorded round closed around 2012-03-01.
Valuation (modeled)modeled
Provath models Hypertension Diagnostics Inc /Mn at approximately $46M (range $445K–$522M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.35× the median modeled value of Pre-Seed Biotechnology companies in 2010–2012 (132 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 14.3 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 16% of Biotechnology peers (4293 compared).
Modeled value ranks above 43% of those peers.
Closest niche peers: Hygeia Therapeutics, Inc., Act Biotech Inc, Ikonopedia, LLC, Iquum Inc, Koronis Pharma, Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.